• 검색 결과가 없습니다.

Anti-Heparin-Platelet Factor 4 Antibody is a Risk Factor for VascularAccess Obstruction in Patients Undergoing Hemodialysis

N/A
N/A
Protected

Academic year: 2021

Share "Anti-Heparin-Platelet Factor 4 Antibody is a Risk Factor for VascularAccess Obstruction in Patients Undergoing Hemodialysis"

Copied!
4
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

참조

관련 문서

(Method) The study subjects were 25 cancer patients out of 796 end-stage renal disease (ESRD) patients maintained on hemodialysis or peritoneal dialysis at Chosun

Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a

Objective :::: The neovascularization is an essential a factor for the growth of solid organ cancer, and especially vascular endothelial growth factor (VEGF)

The students of Gwangju Secondary School had to compete with the students of Gwangju Intermediate School, who were Japanese nationals for access to a

It might also act in conjunction with a growth factor, such as bone morphogenic protein (BMP), insulin-like growth factor, or platelet-derived growth factor.

First, as for the relationship between interest factor and self-esteem formation, human relation factor as an interest factor had a significant effect at

For example, the public’s sentiments of risk regarding nuclear power plants exceeds the risk felt by an expert in the area, and therefore the public sentiment is a negative

In this study, platelet-derived growth factors-BB (PDGF-BB), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1) were quantified in the PRF